Study Reveals New Insights on How Brain Cancer Spreads

by Sheela Philomena on November 19, 2016 at 6:17 PM

A new pathway by which cancer cells aggressively spread and grow in the brain has been discovered by researchers. The finding opens up new possibilities for treatment.

Study findings were published in the Nov. 17 online version of Cell. Co-authors included Baoli Hu, Ph.D., senior research scientist, Y. Alan Wang, Ph.D., associate professor, and Ronald A. DePinho, M.D., professor, all of Cancer Biology, and Qianghu Wang Ph.D., Bioinformatics and Computational Biology.

Brain Tumor

Brain tumors are the abnormal growth of brain cells that may be benign or metastatic. Brain tumors account for about 2.4% of all the tumor diagnosesandare most challenging due to their critically delicate location.

‘Glioblastoma (brain tumor) model to locate glioma stem cells, which, like all stem calls, have the ability to become other cell types developed.’

Tweet it Now

"The poor prognosis of glioblastoma relates to the near universal recurrence of tumors despite robust treatment including surgery, radiotherapy and chemotherapy," said Hu. "Our study shows the potential for a new therapeutic strategy based on targeting the mechanisms allowing glioma to re-grow aggressively in the brain."

The researchers further found that the gene, WNT5A, when activated, allowed glioma stem cells to transition, leading to invasive tumor growth.

"We uncovered a process by which glioma stem cells mediated by the WNT5A gene become endothelial-like cells," said Hu. "These new cells known as GdECs, recruit existing endothelial cells to form a niche supporting the growth of invasive glioma cells away from the primary tumor, and often leading to satellite "lesions" and disease recurrence."

Quiz on Brain Tumor

Brain tumor is a group of cells with abnormal growth in the brain. A primary brain tumor indicates the tumor that starts in the brain. A secondary tumor originates elsewhere in the body and then spreads to the brain.

Clinical data revealed higher WNT5A and GdECs expression in these satellite lesions and recurrent tumors than was observed in the primary tumors, affirming the tie between WNT5A-mediated stem cell differentiation and glioma cell spread throughout the brain, and contributing to the cancer's lethalness.

The study established WNT5A as a key factor in glioma stem cells transitioning to GdECs. The team believes this opens up the possibility for a new therapeutic strategy for patients with glioblastoma.

Recent clinical data show the FDA-approved drug, bevacizumab, did not benefit patients as a first line treatment of recurrent glioblastoma by targeting vascular endothelial growth factors (VEGF). With this new information, the study team proposes an additional therapeutic approach targeting WNT5A and VEGF signaling pathways for recurrent glioblastoma.

"Our preliminary data show that bevacizumab may increase WNT5A-mediated GdECs differentiation and recruitment of existing endothelial cells resulting in no proven benefit to patients with glioblastoma" said Hu. "This new strategy should improve the outcome of brain cancer patients undergoing VEGF therapy, by limiting new tumor growth and invasion, and disease recurrence," said Hu.

Source: Eurekalert

Better Possible Treatments for Brain Cancer in Children

Each year, more than 4,000 children and teens are diagnosed with brain cancer and the disease kills more children than any other cancer.

<< An Internal ‘Quality Control’ in T Cell Development

Here's How You can Avoid Violent or Sexual Dreams >>

The Saga Of Deadly Brain Cancer Cells

Adult brain cancers are almost universally fatal, in part because of the biochemical composition of the central nervous system and the blood-brain barrier.